Skip to Main Content

Christopher B. Ferenc

Associate
christopher.ferenc@kattenlaw.com
Washington, DC Office
p+1.202.625.3647
f+1.202.339.6044
Overview

Christopher Ferenc, a registered patent attorney, devotes his practice to counseling clients on intellectual property matters across a diverse array of technologies, including pharmaceuticals, specialty chemicals, medical devices, cosmetics, mechanical devices, computer network security, e-mail message filtration, navigational instruments, wearables and athletic garments.

Chris has extensive experience representing both plaintiffs and defendants in patent litigation arising in the US Federal District Courts. He frequently represents pharmaceutical companies engaged in complex patent disputes arising under the Hatch-Waxman Act, and manages all facets of patent litigation, including pre-suit investigation, fact and expert discovery, dispositive motions, pre-trial preparation, and trial. Chris has also represented clients in inter partes review proceedings before the Patent Trial and Appeal Board.

In addition to his litigation practice, Chris routinely advises clients on strategic patent planning, including patent prosecution of US and foreign patent portfolios, due diligence, licensing, freedom-to-operate studies, patent landscape analysis, and validity and infringement opinions.

Shown below is a selection of Christopher’s engagements.

Experience
  • Representation of Sawai in patent litigation surrounding a proposed generic version of Myrbetriq® (mirabegron). Currently litigating.
  • Representation of a Japanese pharmaceutical company in patent litigation surrounding a proposed generic version of Tecfidera® (dimethyl fumarate). Currently litigating.
  • Representation of Qilu in patent litigation surrounding a proposed generic version of Aloxi® (palonosetron). Favorable confidential settlement reached.
  • Representation of Apotex in patent litigation surrounding a proposed generic version of Azilect® (rasagiline mesylate). Favorable confidential settlement reached just before trial.
  • Representation of a generic drug manufacturer in patent litigation surrounding a proposed generic version of Astepro® (azelastine). Favorable confidential settlement reached.
  • Representation of Strides in patent litigation surrounding proposed generic versions of Zometa® and Reclast® (zoledronic acid). Representation ended after Strides was purchased by Mylan.
  • Representation of a defense contractor during inter partes review proceeding before the Patent Trial and Appeal Board concerning its patented technology supporting the navigation system in a pilot helmet. Representation ended after filing patent owner response.
  • Representation of a defense contractor during appeal of decision from Court of Federal Claims regarding § 101 issues concerning its patented technology supporting the navigation system in a pilot helmet. Representation ended after filing appeal brief.
  • Representation of an athletic garment manufacturer against inter partes review challenge before the Patent Trial and Appeal Board concerning its patented moisture control garment technology. Favorable confidential settlement reached.
  • Representation of an athletic garment manufacturer as plaintiff in patent litigation concerning its patented moisture control garment technology. Favorable confidential settlement reached.
  • Defense of providers of network security services in patent litigation regarding methods of out-of-band authentication. Favorable confidential settlement reached just before trial.
  • Representation of a provider of network security services as plaintiff in patent litigation regarding its patented technology for MDSSO and methods for selectively authenticating and authorizing access to protected computer networks. Favorable confidential settlement reached.
  • Defense of a provider of network security services in patent litigation regarding methods for filtering email messages based on semantic modeling. Favorable dismissal reached.
  • Defense of an electronics technology development company in patent litigation regarding hierarchical storage manager technology. Favorable confidential settlement reached.
  • Defense of a sportswear company in patent litigation regarding methods and systems for physical performance monitoring. Favorable confidential settlement reached.
Christopher B. Ferenc

Education

  • JD, Seton Hall University School of Law
  • BS, Chemistry, specialization in Biochemistry, University of Virginia

Bar Admissions

  • District of Columbia
  • New Jersey
  • Virginia

Court Admissions

  • US District Court, District of New Jersey
  • US Patent & Trademark Office

Memberships

  • American Bar Association, Administrative Law & Regulatory Practice, Intellectual Property Law, and Science & Technology Law sections
  • American Intellectual Property Law Association
Katten Websites   Careers  |  Alumni  |  Mobile Site
Contact Us   Offices  |  Media Center  |  People  |  Email
Legal Notices   Disclaimer  |  Privacy Notice  |  Cookie Notice  |  United Kingdom Notices  | Accessibility 
© 2018 Katten Muchin Rosenman LLP